1Cancer Research Horizons, CRUK, The Francis Crick Institute, London, UK
2Cancer Research UK, London, UK
3Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK
4Illumina Cambridge, Great Abington, Cambridge, UK
5All Wales Medical Genomics Service, University Hospital of Wales, Cardiff, UK
6The Centre for Molecular Pathology, The Royal Marsden, Sutton, UK
7West Midlands Regional Genetics Laboratory, Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, UK
8Genpax AG, Cambridge, UK
9Independent patient representative, Sandwell, West Midlands UK
10Pfizer, Global Product Development Oncology, San Diego, CA USA
11AstraZeneca, Late Development Oncology, Academy House, Cambridge, UK
12The Royal Marsden Hospital NHS Foundation Trust, London, UK
13Institute of Immunology & Immunotherapy, University of Birmingham, Birmingham, UK
14School of Cancer Sciences, University of Southampton, Southampton, UK
15The Francis Crick Institute, Midland Road, London, UK
16Wellcome Trust, London, UK
17Eli Lilly, London, UK
18British Heart Foundation, Bromley, UK
19Silence Therapeutics, London, UK
20Parexel, London, UK
21Ahead Care and Support, London, UK
© The Author(s), under exclusive licence to Springer Nature Limited 2023
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
